Accelerated Clinical Research in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Accelerated Clinical Research in Brazil

Accelerated Clinical Research in Brazil – Human Trials in LATAM

Brazil has emerged as a dynamic hub for accelerated clinical research, fostering an environment that fuels medical breakthroughs. With its robust healthcare infrastructure, diverse patient population, supportive regulatory framework, and a thriving research ecosystem, Brazil offers a compelling platform for conducting clinical trials.

This blog explores the key factors for accelerated clinical research in Brazil, highlighting the benefits it brings to researchers, patients, and the overall advancement of medical science.

Advanced Healthcare Infrastructure and Expertise

Brazil boasts a sophisticated healthcare infrastructure, comprising modern hospitals, specialized clinics, and cutting-edge research facilities. These state-of-the-art facilities provide researchers with access to advanced technologies and comprehensive medical services, ensuring the highest standards of data collection and patient care during clinical trials.

Furthermore, Brazil is home to renowned medical experts and research institutions, offering a wealth of expertise in various fields of medicine. The collaboration between academic institutions, hospitals, and industry partners facilitates multidisciplinary research and knowledge exchange, contributing to accelerated advancements in medical science.

Diverse and Representative Patient Population

Brazil is celebrated for its diverse and genetically heterogeneous population, offering significant advantages for clinical research. The country’s population comprises various ethnicities, including Indigenous, African, European, and Asian ancestry. This diversity provides researchers with an opportunity to recruit a more representative patient cohort, enabling the study of genetic variations and the potential impact on treatment outcomes.

Moreover, Brazil’s large population size and high disease prevalence contribute to the rapid recruitment and enrollment of participants in clinical trials. This accelerates the research process, enhances statistical power, and fosters the generation of robust and generalizable results.

Supportive Regulatory Environment and Efficient Approval Process

Brazil’s regulatory framework for clinical research is well-established, promoting patient safety and ethical conduct. The National Health Surveillance Agency (ANVISA) oversees the regulation and approval of clinical trials, ensuring compliance with national and international guidelines.

ANVISA has implemented streamlined processes for clinical trial approvals, emphasizing efficiency and transparency. The regulatory body collaborates with researchers and sponsors to expedite the review and approval of study protocols, minimizing administrative burdens and accelerating the initiation of trials.

Furthermore, Brazil’s adherence to international standards, such as Good Clinical Practice (GCP) guidelines, facilitates the acceptance of data generated from clinical trials in the global scientific community. This alignment attracts multinational trials and encourages collaborations with pharmaceutical companies and research organizations.

Accelerated Clinical Research in Brazil

Accelerated Clinical Research in Brazil

Accelerated Clinical Research in Brazil

Research Funding and Collaboration Networks

Brazil’s commitment to advancing clinical research is supported by a range of funding opportunities and research collaborations. The National Council for Scientific and Technological Development (CNPq) and other funding agencies provide grants and financial support to researchers, incentivizing innovative projects and scientific excellence.

Moreover, Brazil actively participates in national and international research networks, promoting collaboration and knowledge sharing. The Brazilian Society of Clinical Research (SBPPC) and other professional associations organize conferences, workshops, and seminars, facilitating networking opportunities and fostering a culture of collaboration.

These research networks also encourage partnerships between academia, government institutions, and the private sector. By leveraging diverse expertise and resources, researchers in Brazil can tackle complex medical challenges and drive accelerated advancements in clinical research.

Market Potential and Access to Pharmaceutical Innovation

Brazil’s large and rapidly growing healthcare market presents significant opportunities for pharmaceutical companies and researchers. Conducting clinical trials in Brazil provides access to a vast patient population and enables the evaluation of treatment efficacy and safety in real-world settings.

Additionally, Brazil’s expanding middle class and increasing healthcare expenditures contribute to a greater demand for innovative therapies. The country’s participation in clinical research allows patients to gain early access to groundbreaking treatments that may not be available through conventional healthcare channels, thus improving health outcomes and access to state-of-the-art medical advancements.

Furthermore, Brazil’s participation in clinical research attracts global pharmaceutical companies and research organizations, fostering collaborations and partnerships.

These partnerships enable knowledge transfer, technology sharing, and the potential for local production of innovative drugs and medical devices. Brazil’s growing importance in the global pharmaceutical market positions it as a key player in driving medical advancements and contributing to the development of novel treatments.

Cultural and Geographic Advantages

Brazil’s cultural diversity and geographic advantages further enhance its appeal as a destination for accelerated clinical research. The country’s rich cultural heritage and vibrant social dynamics create a favorable environment for patient engagement and participation in clinical trials. The population’s openness to medical research and willingness to contribute to scientific advancements facilitate the recruitment and retention of study participants.

Additionally, Brazil’s vast and varied geography provides unique opportunities for conducting research across different regions and climates. This geographical diversity allows for the study of diseases with varying prevalence and environmental factors, leading to a more comprehensive understanding of healthcare challenges and treatment responses.


Brazil’s accelerated clinical research landscape presents a fertile ground for medical advancements and scientific discoveries. With its advanced healthcare infrastructure, diverse patient population, supportive regulatory environment, research collaborations, market potential, and cultural advantages, Brazil offers a compelling platform for researchers and sponsors to conduct clinical trials.

By leveraging these strengths, Brazil not only contributes to the advancement of medical science but also provides its population with access to cutting-edge treatments and therapies. As Brazil continues to nurture its position in clinical research, the potential for transformative breakthroughs and improved healthcare outcomes grows exponentially.

Accelerated Clinical Research in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Accelerated Clinical Research in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Accelerated Clinical Research in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Accelerated Clinical Research in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Accelerated Clinical Research in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Accelerated Clinical Research in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Accelerated Clinical Research in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Accelerated Clinical Research in Brazil

The Cohortias Team

Accelerated Clinical Research in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Accelerated Clinical Research in Brazil

Network & Partnerships